These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38396200)

  • 1. Serum prolactin levels were positively related to metabolic indexes and disorders in male obese patients.
    Ke X; Wang L; Zhao Y; Duan L; Deng K; Yao Y; Pan H; Gong F; Zhu H
    Endocrine; 2024 Jun; 84(3):1097-1107. PubMed ID: 38396200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China.
    Zhang Y; Liu H
    BMJ Open; 2022 Oct; 12(10):e062252. PubMed ID: 36192106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal serum prolactin levels in obesity--unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss.
    Ernst B; Thurnheer M; Schultes B
    Obes Surg; 2009 Aug; 19(8):1159-62. PubMed ID: 19430852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.
    Zhang J; Guan J; Tang X; Xu J
    Horm Metab Res; 2023 Apr; 55(4):251-255. PubMed ID: 36849108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.
    Wu LM; He H; Chen G; Kuang Y; Lin BY; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):252-257. PubMed ID: 32205038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study.
    Xu P; Zhu Y; Ji X; Ma H; Zhang P; Bi Y
    BMC Gastroenterol; 2022 Dec; 22(1):523. PubMed ID: 36526972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum stromal cell-derived factor-1 concentrations are increased and associated with nonalcoholic fatty liver disease in children with obesity.
    Liu Y; Hao L; Wang L; Lu M; Yin C; Xiao Y
    BMC Endocr Disord; 2024 May; 24(1):67. PubMed ID: 38730413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction.
    Chirico V; Cannavò S; Lacquaniti A; Salpietro V; Mandolfino M; Romeo PD; Cotta O; Munafò C; Giorgianni G; Salpietro C; Arrigo T
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):537-44. PubMed ID: 23445298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.